Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 23Breast 12Genitourinary 11Thoracic 7Head & Neck 6Dermatologic 6Gynecologic 4Other 3CNS 3Lymphoid 2Other hematologic neoplasm 1

Conditions

Pruritus 1Lymphoma, T-Cell, Cutaneous 1Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 282Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lidocaine × Lymphoid × Clear all
NCT04003012 2023-03-09

Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures

CAMC Health System

Phase 4 Completed
10 enrolled 5 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma

NCT00863395 2014-03-31

CTCL

University of Minnesota

Phase 1/2 Terminated
6 enrolled
DermatologicLymphoid

Pruritus, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡